Pascal Magro
Impact in
-
- Pulmonary Hypertension Research and Treatments
-
- Liver Disease and Transplantation
Papers in
-
- Pulmonary Hypertension Research and Treatments 12
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
- Genetics 3
- Vascular Anomalies and Treatments 3
- Co-authors
- Christophe Guignabert (3 shared papers)David Montani (3 shared papers)Marie‐Camille Chaumais (2 shared papers)Xavier Jaïs (3 shared papers)Olivier Sitbon (3 shared papers)Matthieu Canuet (2 shared papers)Laurent Savale (3 shared papers)Marc J.C. Humbert (3 shared papers)
In The Last Decade
Pascal Magro
17 papers receiving 706 citations
Pascal Magro's Hit Papers
Peers
Comparison fields: 5 of 37
- Pulmonary and Respiratory Medicine 524
- Hepatology 50
- Cardiology and Cardiovascular Medicine 86
- Internal Medicine 10
- Hematology 41
Countries citing papers authored by Pascal Magro
This map shows the geographic impact of Pascal Magro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Magro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Magro more than expected).
Fields of papers citing papers by Pascal Magro
This network shows the impact of papers produced by Pascal Magro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Magro. The network helps show where Pascal Magro may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Magro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 153 | |
| 2 | Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study Hit paper breakdown → | 2022 | 148 |
| 3 | 2020 | 108 | |
| 4 | 2017 | 105 | |
| 5 | 2010 | 64 | |
| 6 | 2016 | 48 | |
| 7 | 2017 | 26 | |
| 8 | 2005 | 22 | |
| 9 | 2015 | 17 | |
| 10 | 2020 | 16 | |
| 11 | 2022 | 12 | |
| 12 | 2013 | 10 | |
| 13 | 2020 | 3 | |
| 14 | 2023 | 3 | |
| 15 | 2008 | 1 | |
| 16 | 2011 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2026 | 0 |
About Pascal Magro
Pascal Magro is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Geriatrics and Gerontology, Critical Care and Intensive Care Medicine and Toxicology, having authored 18 papers that have together received 738 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (12 papers), Vascular Anomalies and Treatments (3 papers), Gastrointestinal Bleeding Diagnosis and Treatment (1 paper), Antifungal resistance and susceptibility (1 paper), Ultrasound in Clinical Applications (1 paper), Cardiac pacing and defibrillation studies (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Pharmacovigilance and Adverse Drug Reactions (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (524 citations), Hepatology (50 citations), Cardiology and Cardiovascular Medicine (86 citations), Internal Medicine (10 citations) and Hematology (41 citations). Pascal Magro has collaborated with scholars based in France, Canada and Belgium. Frequent co-authors include Christophe Guignabert, David Montani, Marie‐Camille Chaumais, Xavier Jaïs, Olivier Sitbon, Matthieu Canuet, Laurent Savale, Marc J.C. Humbert, Andrei Seferian and Hélène Bouvaist. Their work appears in journals such as European Respiratory Journal, American Journal of Respiratory and Critical Care Medicine, Transplantation, British Journal of Clinical Pharmacology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.